Community Scoop » Boehringer Ingelheim Enters Global Licensing Agreement To Develop And Commercialize Innovative Antibodies From A*STAR

Scoop Community provides New Zealand Community news and views

Related Keywords

Germany ,Ingelheim ,Rheinland Pfalz ,Singapore ,Engagers Tces ,Biophotonics Bioimaging ,Damian Oconnell ,Cliver Wood ,Agency For Science ,Research Partners ,Boehringer Ingelheim ,Technology Organisation ,Experimental Drug Development Centre ,Genome Institute Of Singapore ,Singapore Gastric Cancer Consortium ,Experimental Biotherapeutics Centre ,Experimental Therapeutics Centre ,Animal Health ,Translational Research ,Institute Of Bioengineering Bioimaging ,Press Release ,Antibody Drug Conjugate ,Senior Corporate Vice President ,Global Head ,Discovery Research ,Drug Development Centre ,Damiano Connell ,Chief Executive Officer ,Tan Sze Wee ,Assistant Chief Executive ,Singapore Gastric Cancer ,Human Pharma ,Biopharmaceutical Contract ,Antibody Drug Conjugates ,Genome Institute ,Human Genetics ,Infectious Diseases ,Cancer Therapeutics ,Stratified Oncology ,Stem Cell ,Regenerative Biology ,Cancer Stem Cell Biology ,Systems Biology ,Bioengineering Systems ,Biomedical Devices ,Scoop ,Community ,New Zealand ,Z ,